Identified Cell Line and Differentiation Target:

Human embryonic stem cells
Cardiomyocytes, endothelial cells, vascular smooth muscle cells

Differentiation Protocol:

Based on the provided data, I'll reconstruct the protocol in the desired structure. Since some steps are missing information and rely on the 'source_documents' field, I'll make use of that to fill in the gaps.

```markdown
# Protocol for Differentiation of Cells

## Step 0: Undifferentiated Cells (Day 1)

* Stage: Undifferentiated cells
* Duration: N/A
* Description: Cell culture containing undifferentiated cells.
* Specific Step: N/A
* Media: N/A
* Serums: N/A
* Supplements: N/A
* Growth Factors: N/A
* Cytokines: N/A
* Passaging: N/A
* Markers: N/A

## Step 1: Cell Culture and Preparation (Day 1-3)

* Stage: Undifferentiated cells
* Duration: 2 days
* Description: Cell culture preparation for differentiation.
* Specific Step: Prepare cell culture containing undifferentiated cells in a suitable medium with necessary supplements, growth factors, and cytokines.
* Media: StemPro34 medium (Invitrogen)
* Serums: None specified
* Supplements: VEGF (25 ng/ml), bFGF (10 ng/ml), DKK1 (150 ng/ml) (R&D Systems)
* Growth Factors: VEGF, bFGF
* Cytokines: DKK1
* Passaging: No passaging mentioned
* Markers: None specified

## Step 2: Differentiation Induction (Day 3-5)

* Stage: Early differentiation
* Duration: 2 days
* Description: Differentiation induction of undifferentiated cells using VEGF, bFGF, and DKK1.
* Specific Step: Add VEGF, bFGF, and DKK1 to the cell culture medium to induce differentiation.
* Media: StemPro34 medium (Invitrogen) with VEGF (25 ng/ml), bFGF (10 ng/ml), DKK1 (150 ng/ml)
* Serums: None specified
* Supplements: VEGF, bFGF, DKK1
* Growth Factors: VEGF, bFGF
* Cytokines: DKK1
* Passaging: No passaging mentioned
* Markers: None specified

## Step 3: Morphological Differentiation (Day 5-7)

* Stage: Morphologically differentiated cells
* Duration: 2 days
* Description: Cells undergo morphological changes after differentiation induction.
* Specific Step: Monitor cell morphology and observe changes in cell shape, size, and organization.
* Media: StemPro34 medium (Invitrogen) with VEGF (25 ng/ml), bFGF (10 ng/ml), DKK1 (150 ng/ml)
* Serums: None specified
* Supplements: VEGF, bFGF, DKK1
* Growth Factors: VEGF, bFGF
* Cytokines: DKK1
* Passaging: No passaging mentioned
* Markers: None specified

## Step 4: Final Differentiation (Day 7-14)

* Stage: Fully differentiated cells
* Duration: 7 days
* Description: Cells reach full differentiation and are ready for analysis.
* Specific Step: Continue to maintain cell culture with VEGF, bFGF, and DKK1 until cells have reached full differentiation.
* Media: StemPro34 medium (Invitrogen) with VEGF (25 ng/ml), bFGF (10 ng/ml), DKK1 (150 ng/ml)
* Serums: None specified
* Supplements: VEGF, bFGF, DKK1
* Growth Factors: VEGF, bFGF
* Cytokines: DKK1
* Passaging: No passaging mentioned
* Markers: None specified

## Step 5: Analysis and Characterization (Day 14+)

* Stage: Fully differentiated cells
* Duration: N/A
* Description: Analyze and characterize the fully differentiated cells.
* Specific Step: Use various techniques, such as RT-PCR, immunofluorescence, colony assays, and patch clamp recordings to analyze and characterize the fully differentiated cells.
* Media: N/A
* Serums: N/A
* Supplements: N/A
* Growth Factors: N/A
* Cytokines: N/A
* Passaging: N/A
* Markers: Specific markers for cell type will be used (e.g., CD31, VE-cadherin)
```

Note that some steps may have overlapping information or missing details. The protocol can be refined and updated as more information becomes available. Additionally, the specific cell type being differentiated is not specified in the provided data, so the markers and growth factors used will depend on the actual cell type being studied.